What are Vir Biotechnology, Inc.'s profit margins?

Vir Biotechnology, Inc. (VIR) runs a 96.1% gross margin and a -720.8% operating margin, with a -676.0% net margin.

Where do Vir Biotechnology, Inc.'s ratios come from?

Every ratio is computed from Vir Biotechnology, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Vir Biotechnology, Inc. VIR Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-699.2%+92.1pp	-791.3%+2.8pp	-794%—	——
Net margin	-638.9%+64.5pp	-703.4%+10.4pp	-713.8%—	——
EBITDA margin	-682.1%+89.5pp	-771.7%+0.1pp	-771.7%—	——
Free cash flow margin	-578.5%+32.8pp	-611.4%+317pp	-928.7%-1,027pp	98.7%+105pp
Returns
Return on equity	-45.7%-7.6pp	-38.1%-4.6pp	-33.5%—	——
Return on assets	-36.5%-5.0pp	-31.5%-5.4pp	-26.1%—	——
Return on invested capital	-61.8%-12.5pp	-49.3%-0.2pp	-49%—	——
Efficiency
Asset turnover	0.1×0.0×	0×0.0×	0×-0.6×	0.7×-0.1×
Liquidity
Current ratio	5.5×-3.2×	8.7×-0.3×	9.1×+4.1×	4.9×+0.3×
Quick ratio	5.5×-3.2×	8.7×-0.3×	9.1×+4.1×	4.9×+0.3×
Cash ratio	2.6×-0.1×	2.7×+1.2×	1.5×-0.2×	1.7×+0.6×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×0.0×	0×0.0×
Per Share
Book value per share	$5.52-34.6%	$8.44-28.8%	$11.86-23.1%	$15.41+43.6%
Valuation
Market capitalization	$838.92M-17.0%	$1.01B-25.4%	$1.35B-59.8%	$3.37B-38.5%
Enterprise value	$695.71M-11.9%	$790.06M-35.1%	$1.22B-53.7%	$2.63B-50.0%
Price / sales	12.2×-1.4×	13.6×-2.1×	15.7×+13.6×	2.1×-2.9×
Price / book	1.1×+0.2×	0.9×0.0×	0.9×-0.8×	1.6×-2.2×
EV / sales	10.1×-0.5×	10.6×-3.5×	14.1×+12.5×	1.6×-3.2×
Free cash flow yield	-47.3%-2.4pp	-44.9%+14.2pp	-59.1%-106pp	47.3%+48.6pp
Earnings yield	-52.2%-0.6pp	-51.6%-6.2pp	-45.4%—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Vir Biotechnology, Inc.'s profit margins?: Vir Biotechnology, Inc. (VIR) runs a 96.1% gross margin and a -720.8% operating margin, with a -676.0% net margin.
Where do Vir Biotechnology, Inc.'s ratios come from?: Every ratio is computed from Vir Biotechnology, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.